• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAJ052502E
Device Problem Separation Failure (2547)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/10/2020
Event Type  malfunction  
Manufacturer Narrative
Lot/serial numbers were not provided, therefore, a review of the manufacturing records could not be conducted.
 
Event Description
It was reported that on an unknown date, the patient was intended to be treated with a gore® viabahn® endoprosthesis.It was reported that the deployment line ¿was cut off¿ in the middle of the deployment.The physician solved the issue and the patient tolerated the procedure.
 
Manufacturer Narrative
Patient identifier: updated.Date of event: updated.Event: updated.Corrected combination product.Updated method, result and conclusion codes.The deployment line, deployment knob, and delivery catheter were returned to w.L.Gore & associates for evaluation.The following observations were made: there was approximately 177 cm of deployment line returned including a 9.5 cm single fiber on the end of the deployment line.The dual lumen appeared to be cut 30 cm from the hub.The remainder of the device appeared to be unremarkable.Engineering evaluation conclusion is inconclusive as it relates to the event description.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Event Description
It was reported that on (b)(6) 2020, the patient presented with femoropopliteal occlusion in the left leg that was treated with the implantation of a gore® viabahn® endoprosthesis (vb).The vb was advanced antegrade over a 0.0018¿ terumo glidewire advantage guidewire through a 6f cordis brite-tip sheath.It was stated that the vb easily passed a 3 mm predilated long ¿semifresh¿ occlusion.The vb was easily positioned with the distal end in the popliteal artery without friction or resistance.During the deployment of the vb, the deployment line separated after approx.10 cm stent deployment.The physician stated that it was unsuccessfully tried to retrieve the deployment line by taking apart the delivery system.Therefore a long sheath was introduced over the catheter and it was managed to deploy the vb by retracting the catheter in increments while holding some forward pressure on the introducer sheath.At the end of the procedure the vb was deployed at the intended position and the procedure successfully completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9942108
MDR Text Key195589533
Report Number2017233-2020-00239
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberPAJ052502E
Device Lot Number20764861
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient Weight77
-
-